WT1 Vaccine Treatment of Patients With Multiple Myeloma After Autologous Stem Cell Transplantation
Clinical trial NCT01827137 · COMPLETED
Trial details
- NCT number
- NCT01827137
- Sponsor
- Sellas Life Sciences Group
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2016-12-07
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.